# NEUROONE MEDICAL TECHNOLOGIES Corp: filings

NMTC · Nasdaq · CIK 1500198 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/nmtc.md) · [Financials](/companies/nmtc/financials.md) · [Filings](/companies/nmtc/filings.md) · [Insiders](/companies/nmtc/insiders.md)

## Reports and events: 260 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 204, 8-K 149, 10-Q 46, 3 23, UPLOAD 15, 10-K 14, 424B5 14, CORRESP 14, NT 10-Q 14, D 11, EFFECT 11, DEF 14A 9, 424B3 8, S-1/A 8, S-8 8, SC 13D 8, 10-K/A 7, SCHEDULE 13G/A 7, 144 6, 8-K/A 6, NT 10-K 6, S-1 6, SC 13D/A 5, SC 13G 5, ARS 4, D/A 4, PRE 14A 4, SC 13G/A 4, SCHEDULE 13G 4, SD 4, S-3 3, 10-Q/A 2, DEFA14A 2, POS AM 2, S-3/A 2, 10-KT 1, 10-KT/A 1, 3/A 1, 4/A 1, 8-A12B 1, 8-A12G 1, CERT 1, CT ORDER 1, DEF 14C 1, DEL AM 1, PRE 14C 1, PRER14A 1, PRER14C 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-05 | 13:20 ET | [8-K](/filings/0001213900-26-106677.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-106677 |
| 2026-08-27 | 13:05 ET | [8-K](/filings/0001213900-26-094174.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-094174 |
| 2026-08-13 | 12:20 ET | [10-Q](/filings/0001213900-26-088724.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088724 |
| 2026-08-13 | 12:15 ET | [8-K](/filings/0001213900-26-088719.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088719 |
| 2026-06-12 | 20:45 ET | [8-K](/filings/0001213900-26-068327.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-068327 |
| 2026-06-12 | 20:32 ET | [10-Q/A](/filings/0001213900-26-068307.md) | Quarterly report, amended, period 2026-03-31 | 0001213900-26-068307 |
| 2026-05-22 | 20:30 ET | [8-K](/filings/0001213900-26-060600.md) | 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-060600 |
| 2026-05-12 | 12:15 ET | [10-Q](/filings/0001213900-26-054749.md) | Quarterly report, period 2026-03-31 | 0001213900-26-054749 |
| 2026-05-12 | 12:10 ET | [8-K](/filings/0001213900-26-054744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-054744 |
| 2026-05-04 | 12:30 ET | [8-K](/filings/0001213900-26-051158.md) | 8.01 Other events | 0001213900-26-051158 |
| 2026-04-30 | 12:30 ET | [8-K](/filings/0001213900-26-049748.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-049748 |
| 2026-04-14 | 12:30 ET | [8-K](/filings/0001213900-26-043239.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-043239 |
| 2026-04-03 | 20:45 ET | [8-K](/filings/0001213900-26-039992.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-039992 |
| 2026-03-09 | 12:00 ET | [DEF 14A](/filings/0001213900-26-024927.md) | Proxy statement, period 2026-04-03 | 0001213900-26-024927 |
| 2026-02-25 | 21:30 ET | [8-K](/filings/0001213900-26-020400.md) | 8.01 Other events | 0001213900-26-020400 |
| 2026-02-17 | 13:00 ET | [8-K](/filings/0001213900-26-016912.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-016912 |
| 2026-02-17 | 12:01 ET | [10-Q](/filings/0001213900-26-016860.md) | Quarterly report, period 2025-12-31 | 0001213900-26-016860 |
| 2026-01-23 | 21:30 ET | [10-K/A](/filings/0001213900-26-007245.md) | Annual report, amended, period 2025-09-30 | 0001213900-26-007245 |
| 2025-12-22 | 13:13 ET | [8-K](/filings/0001213900-25-124165.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-124165 |
| 2025-12-17 | 13:00 ET | [8-K](/filings/0001213900-25-122541.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-122541 |
| 2025-12-17 | 23:05 ET | [10-K](/filings/0001213900-25-122390.md) | Annual report, period 2025-09-30 | 0001213900-25-122390 |
| 2025-11-05 | 13:54 ET | [8-K](/filings/0001213900-25-106454.md) | 3.01 Delisting notice | 0001213900-25-106454 |
| 2025-10-06 | 20:19 ET | [8-K](/filings/0001213900-25-096548.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-096548 |
| 2025-08-18 | 12:42 ET | [8-K](/filings/0001213900-25-077726.md) | 8.01 Other events | 0001213900-25-077726 |
| 2025-08-15 | 20:40 ET | [8-K](/filings/0001213900-25-077511.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-077511 |
| 2025-08-14 | 12:31 ET | [10-Q](/filings/0001213900-25-076080.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076080 |
| 2025-08-14 | 11:46 ET | [8-K](/filings/0001213900-25-076039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076039 |
| 2025-05-13 | 12:15 ET | [8-K](/filings/0001213900-25-042270.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042270 |
| 2025-05-13 | 12:01 ET | [10-Q](/filings/0001213900-25-042266.md) | Quarterly report, period 2025-03-31 | 0001213900-25-042266 |
| 2025-05-09 | 20:30 ET | [8-K](/filings/0001213900-25-041554.md) | 3.01 Delisting notice | 0001213900-25-041554 |
| 2025-04-07 | 20:30 ET | [8-K](/filings/0001213900-25-029442.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-029442 |
| 2025-02-20 | 21:15 ET | [8-K/A](/filings/0001213900-25-015683.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-015683 |
| 2025-02-14 | 21:15 ET | [8-K](/filings/0001213900-25-014281.md) | 5.07 Shareholder vote results | 0001213900-25-014281 |
| 2025-02-12 | 13:30 ET | [10-Q](/filings/0001213900-25-012511.md) | Quarterly report, period 2024-12-31 | 0001213900-25-012511 |
| 2025-02-12 | 13:15 ET | [8-K](/filings/0001213900-25-012510.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-012510 |
| 2025-02-04 | 21:15 ET | [8-K](/filings/0001213900-25-010083.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010083 |
| 2025-01-21 | 21:15 ET | [DEF 14A](/filings/0001213900-25-005016.md) | Proxy statement, period 2025-02-14 | 0001213900-25-005016 |
| 2025-01-14 | 13:30 ET | [8-K](/filings/0001213900-25-003166.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-003166 |
| 2025-01-10 | 22:04 ET | [8-K](/filings/0001213900-25-002728.md) | 3.01 Delisting notice | 0001213900-25-002728 |
| 2025-01-10 | 14:00 ET | [8-K](/filings/0001213900-25-002381.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-002381 |
| 2024-12-17 | 13:40 ET | [8-K](/filings/0001213900-24-109529.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-109529 |
| 2024-12-17 | 13:29 ET | [10-K](/filings/0001213900-24-109524.md) | Annual report, period 2024-09-30 | 0001213900-24-109524 |
| 2024-11-08 | 21:30 ET | [8-K](/filings/0001213900-24-095934.md) | 1.02 Termination of a material agreement | 0001213900-24-095934 |
| 2024-10-31 | 20:05 ET | [8-K](/filings/0001213900-24-092879.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-092879 |
| 2024-09-13 | 20:30 ET | [8-K](/filings/0001213900-24-078584.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-078584 |
| 2024-08-14 | 20:15 ET | [8-K](/filings/0001213900-24-069036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-069036 |
| 2024-08-14 | 12:59 ET | [10-Q](/filings/0001213900-24-068633.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068633 |
| 2024-08-07 | 20:30 ET | [8-K](/filings/0001213900-24-066142.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-066142 |
| 2024-07-12 | 20:49 ET | [8-K](/filings/0001213900-24-061064.md) | 3.01 Delisting notice | 0001213900-24-061064 |
| 2024-06-21 | 20:15 ET | [8-K](/filings/0001213900-24-054782.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-24-054782 |

Page 1 of 6. [Older](/companies/nmtc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.